StradBio
StradBio

Sr Analytical/QC scientist - ADC development

TLDR

Lead development and lifecycle management of analytical methods for ADC programs to enable IND and clinical-stage work.

Position Summary
We are seeking a highly motivated CMC focused Analytical Scientist with deep expertise in analytical method development, qualification, and validation, and a strong foundation in Quality Control to support antibody-drug conjugate (ADC) programs. This role will lead the design, execution, and lifecycle management of robust analytical methods to ensure product quality, support process development, and enable IND and clinical-stage programs.

This role requires demonstrated expertise in ADC-specific analytical challenges, including drug-to-antibody ration (DAR), aggregation, free payload quantification, and stability-indicating methods. Experience supporting CMC regulatory filings, assay control strategies, and management experience with external vendors is essential. A strong understanding of phase-appropriate analytical requirements and readiness for GMP environments is expected.

Key Responsibilities

  • Develop, qualify, and validate analytical methods in accordance with ICH guidelines (Q2(R1)/Q14) to support ADC programs through clinical stages.
  • Execute method transfer activities to external CROs/CDMOs and provide oversight to ensure successful implementation and lifecycle management.
  • Design and author validation protocols, reports, and method lifecycle documentation for regulatory submissions (IND/IMPD).
  • Support release and stability testing strategies, including specification setting and trending of critical quality attributes (CQAs).
  • Investigate out-of-specification (OOS) and out-of-trend (OOT) results, driving root cause analysis and corrective actions.
  • Collaborate cross-functionally with process development, manufacturing, regulatory, and quality teams to ensure alignment on CMC strategy.
  • Contribute to analytical control strategy development, including identification of critical methods and validation requirements.
  • Evaluate and implement new analytical technologies to enhance characterization of complex ADC modalities.

Qualifications

  • Ph.D. in Analytical Chemistry, Biochemistry, or related field with 5–15 years of industry experience; or M.S./B.S. with 10+ years of relevant experience.
  • Direct experience with method qualification and validation for biologics; ADC-specific experience required.
  • Deep understanding of analytical techniques for protein and ADC characterization (e.g., DAR determination, aggregation, charge variants).
  • Working knowledge of regulatory expectations for analytical methods (ICH Q2, Q6B, Q14, USP).
  • Experience working with external partners (CROs/CDMOs) and managing method transfers.
  • Strong technical writing skills with experience contributing to regulatory filings.
  • Ability to work in a fast-paced, collaborative startup or early-stage biotech environment.

Preferred Experience

  • Familiarity with linker-payload stability, free drug quantitation, and bioanalytical interfaces.
  • Exposure to GMP environments and QC assay lifecycle management.

What We Offer

  • Opportunity to work on next-generation ADCs and complex biologics.
  • High-impact role with visibility across CMC and regulatory strategy.
  • Collaborative, science-driven team environment.

Benefits

Collaborative, science-driven team environment

StradBio is a biotechnology startup focused on developing innovative therapies for cancer, with active programs across multiple phases of clinical development. We cater to the oncology market, working on treatments for various types of tumors, including lymphoma and immuno-oncology solutions.

View company profile

This job is no longer available

Pro members saw this job first

New jobs unlock for everyone after 24 hours. Startup Jobs Pro shows them right away, with instant alerts and salary filters. From $7/month.

Get Pro